24/07/2014
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers from the Universitat Politècnica de Catalunya - BarcelonaTech (UPC), the Institute of Medical Chemistry (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria. They have analysed the crystalline structure of the DNA with the drug by performing X-ray diffraction experiments at the ALBA Synchrotron. This work has been published in the journal Acta Crystallographica D.
Read the full press release published by the ALBA Synchrotron
Read the full press release published by the ALBA Synchrotron
More news
10/04/2019
10th Anniversary of the MELiSSA Pilot Plant: travelling to Mars is in progress near the Barcelona Synchrotron Park
25/03/2019
Barcelona Synchrotron Park Sponsors the 9th Ideas Generation Program
08/03/2019
The Barcelona Synchrotron Park aims to host a university residence
01/03/2019
Delegates of the Mobile World Congress discover the park
22/02/2019
Hub b30 takes off
16/02/2019
SENER: wind, sun and moon